Abstract: A multilayer ceramic capacitor may include a ceramic body including a first surface and a second surface facing each other in a first direction, a third surface and a fourth surface facing each other in a second direction and connecting the first surface and the second surface, a fifth surface and a sixth surface facing each other in a third direction and connecting the first surface and the second surface, a plurality of first internal electrodes and a plurality of second internal electrodes disposed inside the ceramic body, and a first external electrode disposed outside the ceramic body, where the first external electrode may include a first metal layer disposed on the first surface and the sixth surface of the ceramic body and electrically connected to the plurality of first internal electrodes on the first surface, and a first plated layer disposed on the first metal layer.

Abstract: The present invention relates to a positive electrode active material and a lithium secondary battery including the same, and more particularly, to a positive electrode active material capable of maintaining the electrochemical properties of a lithium secondary battery using a lithium composite oxide as a positive electrode active material while preventing and/or mitigating gas generation and swelling due to the positive electrode active material in a lithium secondary battery by suppressing the excessive growth of primary particles and improving the crystallinity of primary particles, and a lithium secondary battery including the same.

Abstract: A display device includes a display panel including a display area and a non-display area adjacent to a side of the display area, and a residue trace disposed on the display panel, and disposed on the display area and the non-display area, wherein an outer boundary of the residue trace is adjacent to an edge portion of the display panel, and disposed to be closer to a center portion of the display panel than the edge portion of the display panel.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a cancer cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the cancer cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis.

Abstract: A multilayered capacitor includes: a body including a first internal electrode and a second internal electrode disposed in a first direction while having a dielectric layer therebetween; and a first external electrode and a second external electrode respectively disposed at ends of the body in a second direction. The first internal electrode includes a first capacitance forming portion and a plurality of first lead portions extending from the first capacitance forming portion to connect to the first external electrode. The second internal electrode includes a second capacitance forming portion overlapping the first capacitance forming portion in the first direction and a plurality of second lead portions extending from the second capacitance forming portion to connect to the second external electrode. For a thickness in the first direction, one of the plurality of the first lead portion has a thickness smaller than a thickness of the first capacitance forming portion.

Abstract: A multilayer electronic component includes a body including a capacitance formation portion including dielectric layers and internal electrodes alternately disposed in a first direction, and a cover portion disposed on both end surfaces of the capacitance formation portion, facing each other in the first direction, and having a first surface and a second surface opposing each other in the first direction, a third surface and a fourth surface connected to the first and second surfaces and opposing each other in a second direction, and a fifth surface and a sixth surface connected to the first to fourth surfaces and opposing each other in a third direction, and external electrodes disposed on the third and fourth surfaces. The internal electrodes and the dielectric layers protrude more outwardly than the cover portion in the second direction, and a groove is disposed at an end of the dielectric layer in the second direction.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a cancer cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the cancer cell, the therapeutic compound ultimately being internalized by the cancer cell via endocytosis.

Abstract: Therapeutic compounds for inhibiting and reducing the expression of cell surface proteins and methods for treating cancer, inflammation, and diabetes using the therapeutic compounds.

Abstract: A display device includes: a substrate; a display element on the substrate; a capping layer on the display element; and a thin film encapsulation layer on the capping layer, wherein the capping layer includes: a first capping layer on the display element; a second capping layer on the first capping layer, the second capping layer having a refractive index greater than that of the first capping layer; and a third capping layer on the second capping layer, the third capping layer having a refractive index smaller than that of the second capping layer, wherein the second capping layer has a thickness of 30 nanometers (nm) to 60 nm.

Abstract: A polarizing plate and a display device including the same are provided. A polarizing plate includes a polarizer comprising an absorption axis and a transmission axis that intersect each other, a first retardation layer disposed on a surface of the polarizer, and a second retardation layer disposed on another surface opposite to the surface of the polarizer. An in-plane retardation value of the second retardation layer is greater than about 20 nm and less than about 100 nm. An angle between the absorption axis of the polarizer and a retardation axis of the second retardation layer is in a range of about 10° to about 45°.

Abstract: A multilayer electronic component includes a body including a plurality of dielectric layers and a plurality of internal electrodes; and external electrodes disposed on the body, wherein the internal electrode includes Ni, Sr, and Ru, and an average content of (Sr+Ru)/(Ni+Sr+Ru) is more than 0 wt and less than 8.40 wt.

Abstract: A capacitor component includes a body, including a dielectric layer and an internal electrode layer, and an external electrode disposed on the body and connected to the internal electrode layer. At least one hole is formed in the internal electrode layer, and a region, containing at least one selected from the group consisting of indium (In) and tin (Sn), is disposed in the hole. A method of manufacturing a capacitor component includes forming a dielectric green sheet, forming a conductive thin film, including a first conductive material and a second conductive material, on the dielectric green sheet, and sintering the conductive thin film to form an internal electrode layer. The internal electrode layer includes the first conductive material, and a region, including the second conductive material, is formed in the internal electrode layer.

Abstract: A multilayer electronic component includes a body including a dielectric layer and an internal electrode disposed alternately with the dielectric layer, and an external electrode disposed on the body. The internal electrode includes nickel (Ni) and yttrium (Y), and an average thickness of the internal electrode is 50 nm or more to 250 nm or less.

Abstract: A display device includes: a substrate; a display element on the substrate; a capping layer on the display element; an optical layer on the capping layer, and including: a first optical layer on the display element; and a second optical layer on the first optical layer; and a thin film encapsulation layer on the optical layer, and including: a first inorganic encapsulation layer on the second optical layer; an auxiliary layer on the first inorganic encapsulation layer; an organic encapsulation layer on the auxiliary layer; and a second inorganic encapsulation layer on the organic encapsulation layer. A refractive index of the second optical layer is smaller than a refractive index of the capping layer, and a refractive index of the first optical layer is between the refractive index of the second optical layer and the refractive index of the capping layer.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a cancer cell.

Abstract: Disclosed is an agent capable of inhibiting the activity or enhancing expression of various cancer-related RNAs in TAMS and cancer cells. Disclosed is also a dual-targeted drug delivery system capable of binding to both tumor cells and macrophages in which the PD-L1 receptor is overexpressed.

Abstract: Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell are described. The therapeutic compounds are configured to bind CD47 on the surface of a red blood cell and to be subsequently transferred to CD47 on the surface of the target cell, the therapeutic compound ultimately being internalized by the target cell via endocytosis. The target cell may be a fibrotic cell.

Abstract: A multilayer electronic component includes a body including a dielectric layer and an internal electrode alternately disposed with the dielectric layer, and an external electrode disposed on the body. A ceramic layer is disposed between the dielectric layer and the internal electrode. When an area ratio occupied by pores with respect to the ceramic layer is Sp1 and an area ratio occupied by pores with respect to the dielectric layer is Sp2, Sp1 is less than 5%, and Sp1<Sp2 is satisfied.

Abstract: A multilayer electronic component includes a body including a capacitance formation portion including dielectric layers and internal electrodes alternately disposed in a first direction, and a cover portion disposed on both end surfaces of the capacitance formation portion, facing each other in the first direction, and having a first surface and a second surface opposing each other in the first direction, a third surface and a fourth surface connected to the first and second surfaces and opposing each other in a second direction, and a fifth surface and a sixth surface connected to the first to fourth surfaces and opposing each other in a third direction, and external electrodes disposed on the third and fourth surfaces. The internal electrodes and the dielectric layers protrude more outwardly than the cover portion in the second direction, and a groove is disposed at an end of the dielectric layer in the second direction.